Global Marijuana Market review

Marijuana Comprehensive Study by Type (Recreational, Medical), Application (Chronic Pain, Arthritis, Migraine, Cancer, Other), Grade (Industrial Grade, Pharmaceutical Grade) Players and Region - Global Market Outlook to 2030

Marijuana Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 27.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Marijuana
Marijuana, a psychoactive drug, has medicinal as well as recreational applications. Though, this drug is illegal in most part of the world but widely consumed by millennial. Growing popularity of marijuana is also attributed by its rising medicinal application. The evolution of medical marijuana or medical cannabis from an illegal drug to a mainstream legalized drug in certain parts of the globe is catalyzing the growth of medical marijuana market. According to a research, medical marijuana is being consumed by more than 12 million people all over the globe for various medical purposes such as depression, cancer, pain management and others.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Billion)
CAGR27.6%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Marijuana market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Cara Therapeutics (United States), Cannabis Sativa (United States), CannaGrow Holdings (United States), United Cannabis (United States), Growblox Sciences (United States), GreenGro Technologies (United States), GW Pharmaceuticals (United Kingdom), Lexaria Corp (Canada) and MMJ America (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Canopy Growth (Canada), Aphria (Canada), Aurora Cannabis Inc.(Canada), mCig Inc. (United States) and Medicine Man (United States).

Segmentation Overview
AMA Research has segmented the market of Global Marijuana market by Type (Recreational and Medical), Application (Chronic Pain, Arthritis, Migraine, Cancer and Other) and Region.



On the basis of geography, the market of Marijuana has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Canada region held largest market share in the year 2023. United States, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Grade, the sub-segment i.e. Industrial Grade will boost the Marijuana market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Emergence of luxury cannabis products, The harmful effects of smoking unregulated volumes of marijuana has led to the advent of nouveau consumption trends of medical marijuana and Top market players are focusing on increasing their production capacities and expanding their business reach.

Market Growth Drivers:
Increasing Demand for both Medical and Recreational Purposes

Challenges:
Development of Side Effects, Limiting Usability and Difficulty in Procurement of License for Production

Restraints:
Stringent FDA and Other Regulations against Sale of Marijuana

Opportunities:
The Asia-Pacific region is anticipated to emerge as a lucrative investment pocket during the upcoming years, owing to the increasing medical complexities in the region and the extensive research being conducted by various Chinese firms. and Various countries such as Israel, United Kingdom and others are focusing on research and technology development.

Market Leaders and their expansionary development strategies
In March 2023, Canopy Growth introduced six new beverage flavors. Under the Deep Space brand, the company announced Canada's first cannabis-infused beverage with naturally occurring caffeine. The company also launched four flavors under the Tweed brand for springtime.
In January 2024, Village Farms International, Inc., announced the launch of two cannabis brands in the UK, such as Pure Sunfarms and The Original Fraser Valley Weed Co. (Fraser Valley). 4C LABS, a UK-based medical cannabis company, will distribute these brands.
Under the Controlled Substances Act (“CSA”), the policies and regulations of the Federal government and its agencies are that cannabis (marijuana) is a stage 1 narcotic that is addictive and has no medical benefit. Accordingly, range of activities including cultivation and the personal use of cannabis is prohibited and subject to prosecution and criminal penalties.

Analyst View
The legal status of medical marijuana across the globe is the most crucial market determinant that is fuelling and hindering the growth of the global market.

Key Target Audience
Pharmaceuticals Companies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Recreational
  • Medical
By Application
  • Chronic Pain
  • Arthritis
  • Migraine
  • Cancer
  • Other
By Grade
  • Industrial Grade
  • Pharmaceutical Grade

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for both Medical and Recreational Purposes
    • 3.3. Market Challenges
      • 3.3.1. Development of Side Effects, Limiting Usability
      • 3.3.2. Difficulty in Procurement of License for Production
    • 3.4. Market Trends
      • 3.4.1. Emergence of luxury cannabis products
      • 3.4.2. The harmful effects of smoking unregulated volumes of marijuana has led to the advent of nouveau consumption trends of medical marijuana
      • 3.4.3. Top market players are focusing on increasing their production capacities and expanding their business reach.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Marijuana, by Type, Application, Grade and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Marijuana (Value)
      • 5.2.1. Global Marijuana by: Type (Value)
        • 5.2.1.1. Recreational
        • 5.2.1.2. Medical
      • 5.2.2. Global Marijuana by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Arthritis
        • 5.2.2.3. Migraine
        • 5.2.2.4. Cancer
        • 5.2.2.5. Other
      • 5.2.3. Global Marijuana by: Grade (Value)
        • 5.2.3.1. Industrial Grade
        • 5.2.3.2. Pharmaceutical Grade
      • 5.2.4. Global Marijuana Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Marijuana (Volume)
      • 5.3.1. Global Marijuana by: Type (Volume)
        • 5.3.1.1. Recreational
        • 5.3.1.2. Medical
      • 5.3.2. Global Marijuana by: Application (Volume)
        • 5.3.2.1. Chronic Pain
        • 5.3.2.2. Arthritis
        • 5.3.2.3. Migraine
        • 5.3.2.4. Cancer
        • 5.3.2.5. Other
      • 5.3.3. Global Marijuana by: Grade (Volume)
        • 5.3.3.1. Industrial Grade
        • 5.3.3.2. Pharmaceutical Grade
      • 5.3.4. Global Marijuana Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Marijuana (Price)
      • 5.4.1. Global Marijuana by: Type (Price)
  • 6. Marijuana: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cara Therapeutics (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cannabis Sativa (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CannaGrow Holdings (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. United Cannabis (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Growblox Sciences (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GreenGro Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GW Pharmaceuticals (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lexaria Corp (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MMJ America (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Marijuana Sale, by Type, Application, Grade and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Marijuana (Value)
      • 7.2.1. Global Marijuana by: Type (Value)
        • 7.2.1.1. Recreational
        • 7.2.1.2. Medical
      • 7.2.2. Global Marijuana by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Arthritis
        • 7.2.2.3. Migraine
        • 7.2.2.4. Cancer
        • 7.2.2.5. Other
      • 7.2.3. Global Marijuana by: Grade (Value)
        • 7.2.3.1. Industrial Grade
        • 7.2.3.2. Pharmaceutical Grade
      • 7.2.4. Global Marijuana Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Marijuana (Volume)
      • 7.3.1. Global Marijuana by: Type (Volume)
        • 7.3.1.1. Recreational
        • 7.3.1.2. Medical
      • 7.3.2. Global Marijuana by: Application (Volume)
        • 7.3.2.1. Chronic Pain
        • 7.3.2.2. Arthritis
        • 7.3.2.3. Migraine
        • 7.3.2.4. Cancer
        • 7.3.2.5. Other
      • 7.3.3. Global Marijuana by: Grade (Volume)
        • 7.3.3.1. Industrial Grade
        • 7.3.3.2. Pharmaceutical Grade
      • 7.3.4. Global Marijuana Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Marijuana (Price)
      • 7.4.1. Global Marijuana by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Marijuana: by Type(USD Billion)
  • Table 2. Marijuana Recreational , by Region USD Billion (2018-2023)
  • Table 3. Marijuana Medical , by Region USD Billion (2018-2023)
  • Table 4. Marijuana: by Application(USD Billion)
  • Table 5. Marijuana Chronic Pain , by Region USD Billion (2018-2023)
  • Table 6. Marijuana Arthritis , by Region USD Billion (2018-2023)
  • Table 7. Marijuana Migraine , by Region USD Billion (2018-2023)
  • Table 8. Marijuana Cancer , by Region USD Billion (2018-2023)
  • Table 9. Marijuana Other , by Region USD Billion (2018-2023)
  • Table 10. Marijuana: by Grade(USD Billion)
  • Table 11. Marijuana Industrial Grade , by Region USD Billion (2018-2023)
  • Table 12. Marijuana Pharmaceutical Grade , by Region USD Billion (2018-2023)
  • Table 13. South America Marijuana, by Country USD Billion (2018-2023)
  • Table 14. South America Marijuana, by Type USD Billion (2018-2023)
  • Table 15. South America Marijuana, by Application USD Billion (2018-2023)
  • Table 16. South America Marijuana, by Grade USD Billion (2018-2023)
  • Table 17. Brazil Marijuana, by Type USD Billion (2018-2023)
  • Table 18. Brazil Marijuana, by Application USD Billion (2018-2023)
  • Table 19. Brazil Marijuana, by Grade USD Billion (2018-2023)
  • Table 20. Argentina Marijuana, by Type USD Billion (2018-2023)
  • Table 21. Argentina Marijuana, by Application USD Billion (2018-2023)
  • Table 22. Argentina Marijuana, by Grade USD Billion (2018-2023)
  • Table 23. Rest of South America Marijuana, by Type USD Billion (2018-2023)
  • Table 24. Rest of South America Marijuana, by Application USD Billion (2018-2023)
  • Table 25. Rest of South America Marijuana, by Grade USD Billion (2018-2023)
  • Table 26. Asia Pacific Marijuana, by Country USD Billion (2018-2023)
  • Table 27. Asia Pacific Marijuana, by Type USD Billion (2018-2023)
  • Table 28. Asia Pacific Marijuana, by Application USD Billion (2018-2023)
  • Table 29. Asia Pacific Marijuana, by Grade USD Billion (2018-2023)
  • Table 30. China Marijuana, by Type USD Billion (2018-2023)
  • Table 31. China Marijuana, by Application USD Billion (2018-2023)
  • Table 32. China Marijuana, by Grade USD Billion (2018-2023)
  • Table 33. Japan Marijuana, by Type USD Billion (2018-2023)
  • Table 34. Japan Marijuana, by Application USD Billion (2018-2023)
  • Table 35. Japan Marijuana, by Grade USD Billion (2018-2023)
  • Table 36. India Marijuana, by Type USD Billion (2018-2023)
  • Table 37. India Marijuana, by Application USD Billion (2018-2023)
  • Table 38. India Marijuana, by Grade USD Billion (2018-2023)
  • Table 39. South Korea Marijuana, by Type USD Billion (2018-2023)
  • Table 40. South Korea Marijuana, by Application USD Billion (2018-2023)
  • Table 41. South Korea Marijuana, by Grade USD Billion (2018-2023)
  • Table 42. Taiwan Marijuana, by Type USD Billion (2018-2023)
  • Table 43. Taiwan Marijuana, by Application USD Billion (2018-2023)
  • Table 44. Taiwan Marijuana, by Grade USD Billion (2018-2023)
  • Table 45. Australia Marijuana, by Type USD Billion (2018-2023)
  • Table 46. Australia Marijuana, by Application USD Billion (2018-2023)
  • Table 47. Australia Marijuana, by Grade USD Billion (2018-2023)
  • Table 48. Rest of Asia-Pacific Marijuana, by Type USD Billion (2018-2023)
  • Table 49. Rest of Asia-Pacific Marijuana, by Application USD Billion (2018-2023)
  • Table 50. Rest of Asia-Pacific Marijuana, by Grade USD Billion (2018-2023)
  • Table 51. Europe Marijuana, by Country USD Billion (2018-2023)
  • Table 52. Europe Marijuana, by Type USD Billion (2018-2023)
  • Table 53. Europe Marijuana, by Application USD Billion (2018-2023)
  • Table 54. Europe Marijuana, by Grade USD Billion (2018-2023)
  • Table 55. Germany Marijuana, by Type USD Billion (2018-2023)
  • Table 56. Germany Marijuana, by Application USD Billion (2018-2023)
  • Table 57. Germany Marijuana, by Grade USD Billion (2018-2023)
  • Table 58. France Marijuana, by Type USD Billion (2018-2023)
  • Table 59. France Marijuana, by Application USD Billion (2018-2023)
  • Table 60. France Marijuana, by Grade USD Billion (2018-2023)
  • Table 61. Italy Marijuana, by Type USD Billion (2018-2023)
  • Table 62. Italy Marijuana, by Application USD Billion (2018-2023)
  • Table 63. Italy Marijuana, by Grade USD Billion (2018-2023)
  • Table 64. United Kingdom Marijuana, by Type USD Billion (2018-2023)
  • Table 65. United Kingdom Marijuana, by Application USD Billion (2018-2023)
  • Table 66. United Kingdom Marijuana, by Grade USD Billion (2018-2023)
  • Table 67. Netherlands Marijuana, by Type USD Billion (2018-2023)
  • Table 68. Netherlands Marijuana, by Application USD Billion (2018-2023)
  • Table 69. Netherlands Marijuana, by Grade USD Billion (2018-2023)
  • Table 70. Rest of Europe Marijuana, by Type USD Billion (2018-2023)
  • Table 71. Rest of Europe Marijuana, by Application USD Billion (2018-2023)
  • Table 72. Rest of Europe Marijuana, by Grade USD Billion (2018-2023)
  • Table 73. MEA Marijuana, by Country USD Billion (2018-2023)
  • Table 74. MEA Marijuana, by Type USD Billion (2018-2023)
  • Table 75. MEA Marijuana, by Application USD Billion (2018-2023)
  • Table 76. MEA Marijuana, by Grade USD Billion (2018-2023)
  • Table 77. Middle East Marijuana, by Type USD Billion (2018-2023)
  • Table 78. Middle East Marijuana, by Application USD Billion (2018-2023)
  • Table 79. Middle East Marijuana, by Grade USD Billion (2018-2023)
  • Table 80. Africa Marijuana, by Type USD Billion (2018-2023)
  • Table 81. Africa Marijuana, by Application USD Billion (2018-2023)
  • Table 82. Africa Marijuana, by Grade USD Billion (2018-2023)
  • Table 83. North America Marijuana, by Country USD Billion (2018-2023)
  • Table 84. North America Marijuana, by Type USD Billion (2018-2023)
  • Table 85. North America Marijuana, by Application USD Billion (2018-2023)
  • Table 86. North America Marijuana, by Grade USD Billion (2018-2023)
  • Table 87. United States Marijuana, by Type USD Billion (2018-2023)
  • Table 88. United States Marijuana, by Application USD Billion (2018-2023)
  • Table 89. United States Marijuana, by Grade USD Billion (2018-2023)
  • Table 90. Canada Marijuana, by Type USD Billion (2018-2023)
  • Table 91. Canada Marijuana, by Application USD Billion (2018-2023)
  • Table 92. Canada Marijuana, by Grade USD Billion (2018-2023)
  • Table 93. Mexico Marijuana, by Type USD Billion (2018-2023)
  • Table 94. Mexico Marijuana, by Application USD Billion (2018-2023)
  • Table 95. Mexico Marijuana, by Grade USD Billion (2018-2023)
  • Table 96. Marijuana Sales: by Type(Tons)
  • Table 97. Marijuana Sales Recreational , by Region Tons (2018-2023)
  • Table 98. Marijuana Sales Medical , by Region Tons (2018-2023)
  • Table 99. Marijuana Sales: by Application(Tons)
  • Table 100. Marijuana Sales Chronic Pain , by Region Tons (2018-2023)
  • Table 101. Marijuana Sales Arthritis , by Region Tons (2018-2023)
  • Table 102. Marijuana Sales Migraine , by Region Tons (2018-2023)
  • Table 103. Marijuana Sales Cancer , by Region Tons (2018-2023)
  • Table 104. Marijuana Sales Other , by Region Tons (2018-2023)
  • Table 105. Marijuana Sales: by Grade(Tons)
  • Table 106. Marijuana Sales Industrial Grade , by Region Tons (2018-2023)
  • Table 107. Marijuana Sales Pharmaceutical Grade , by Region Tons (2018-2023)
  • Table 108. South America Marijuana Sales, by Country Tons (2018-2023)
  • Table 109. South America Marijuana Sales, by Type Tons (2018-2023)
  • Table 110. South America Marijuana Sales, by Application Tons (2018-2023)
  • Table 111. South America Marijuana Sales, by Grade Tons (2018-2023)
  • Table 112. Brazil Marijuana Sales, by Type Tons (2018-2023)
  • Table 113. Brazil Marijuana Sales, by Application Tons (2018-2023)
  • Table 114. Brazil Marijuana Sales, by Grade Tons (2018-2023)
  • Table 115. Argentina Marijuana Sales, by Type Tons (2018-2023)
  • Table 116. Argentina Marijuana Sales, by Application Tons (2018-2023)
  • Table 117. Argentina Marijuana Sales, by Grade Tons (2018-2023)
  • Table 118. Rest of South America Marijuana Sales, by Type Tons (2018-2023)
  • Table 119. Rest of South America Marijuana Sales, by Application Tons (2018-2023)
  • Table 120. Rest of South America Marijuana Sales, by Grade Tons (2018-2023)
  • Table 121. Asia Pacific Marijuana Sales, by Country Tons (2018-2023)
  • Table 122. Asia Pacific Marijuana Sales, by Type Tons (2018-2023)
  • Table 123. Asia Pacific Marijuana Sales, by Application Tons (2018-2023)
  • Table 124. Asia Pacific Marijuana Sales, by Grade Tons (2018-2023)
  • Table 125. China Marijuana Sales, by Type Tons (2018-2023)
  • Table 126. China Marijuana Sales, by Application Tons (2018-2023)
  • Table 127. China Marijuana Sales, by Grade Tons (2018-2023)
  • Table 128. Japan Marijuana Sales, by Type Tons (2018-2023)
  • Table 129. Japan Marijuana Sales, by Application Tons (2018-2023)
  • Table 130. Japan Marijuana Sales, by Grade Tons (2018-2023)
  • Table 131. India Marijuana Sales, by Type Tons (2018-2023)
  • Table 132. India Marijuana Sales, by Application Tons (2018-2023)
  • Table 133. India Marijuana Sales, by Grade Tons (2018-2023)
  • Table 134. South Korea Marijuana Sales, by Type Tons (2018-2023)
  • Table 135. South Korea Marijuana Sales, by Application Tons (2018-2023)
  • Table 136. South Korea Marijuana Sales, by Grade Tons (2018-2023)
  • Table 137. Taiwan Marijuana Sales, by Type Tons (2018-2023)
  • Table 138. Taiwan Marijuana Sales, by Application Tons (2018-2023)
  • Table 139. Taiwan Marijuana Sales, by Grade Tons (2018-2023)
  • Table 140. Australia Marijuana Sales, by Type Tons (2018-2023)
  • Table 141. Australia Marijuana Sales, by Application Tons (2018-2023)
  • Table 142. Australia Marijuana Sales, by Grade Tons (2018-2023)
  • Table 143. Rest of Asia-Pacific Marijuana Sales, by Type Tons (2018-2023)
  • Table 144. Rest of Asia-Pacific Marijuana Sales, by Application Tons (2018-2023)
  • Table 145. Rest of Asia-Pacific Marijuana Sales, by Grade Tons (2018-2023)
  • Table 146. Europe Marijuana Sales, by Country Tons (2018-2023)
  • Table 147. Europe Marijuana Sales, by Type Tons (2018-2023)
  • Table 148. Europe Marijuana Sales, by Application Tons (2018-2023)
  • Table 149. Europe Marijuana Sales, by Grade Tons (2018-2023)
  • Table 150. Germany Marijuana Sales, by Type Tons (2018-2023)
  • Table 151. Germany Marijuana Sales, by Application Tons (2018-2023)
  • Table 152. Germany Marijuana Sales, by Grade Tons (2018-2023)
  • Table 153. France Marijuana Sales, by Type Tons (2018-2023)
  • Table 154. France Marijuana Sales, by Application Tons (2018-2023)
  • Table 155. France Marijuana Sales, by Grade Tons (2018-2023)
  • Table 156. Italy Marijuana Sales, by Type Tons (2018-2023)
  • Table 157. Italy Marijuana Sales, by Application Tons (2018-2023)
  • Table 158. Italy Marijuana Sales, by Grade Tons (2018-2023)
  • Table 159. United Kingdom Marijuana Sales, by Type Tons (2018-2023)
  • Table 160. United Kingdom Marijuana Sales, by Application Tons (2018-2023)
  • Table 161. United Kingdom Marijuana Sales, by Grade Tons (2018-2023)
  • Table 162. Netherlands Marijuana Sales, by Type Tons (2018-2023)
  • Table 163. Netherlands Marijuana Sales, by Application Tons (2018-2023)
  • Table 164. Netherlands Marijuana Sales, by Grade Tons (2018-2023)
  • Table 165. Rest of Europe Marijuana Sales, by Type Tons (2018-2023)
  • Table 166. Rest of Europe Marijuana Sales, by Application Tons (2018-2023)
  • Table 167. Rest of Europe Marijuana Sales, by Grade Tons (2018-2023)
  • Table 168. MEA Marijuana Sales, by Country Tons (2018-2023)
  • Table 169. MEA Marijuana Sales, by Type Tons (2018-2023)
  • Table 170. MEA Marijuana Sales, by Application Tons (2018-2023)
  • Table 171. MEA Marijuana Sales, by Grade Tons (2018-2023)
  • Table 172. Middle East Marijuana Sales, by Type Tons (2018-2023)
  • Table 173. Middle East Marijuana Sales, by Application Tons (2018-2023)
  • Table 174. Middle East Marijuana Sales, by Grade Tons (2018-2023)
  • Table 175. Africa Marijuana Sales, by Type Tons (2018-2023)
  • Table 176. Africa Marijuana Sales, by Application Tons (2018-2023)
  • Table 177. Africa Marijuana Sales, by Grade Tons (2018-2023)
  • Table 178. North America Marijuana Sales, by Country Tons (2018-2023)
  • Table 179. North America Marijuana Sales, by Type Tons (2018-2023)
  • Table 180. North America Marijuana Sales, by Application Tons (2018-2023)
  • Table 181. North America Marijuana Sales, by Grade Tons (2018-2023)
  • Table 182. United States Marijuana Sales, by Type Tons (2018-2023)
  • Table 183. United States Marijuana Sales, by Application Tons (2018-2023)
  • Table 184. United States Marijuana Sales, by Grade Tons (2018-2023)
  • Table 185. Canada Marijuana Sales, by Type Tons (2018-2023)
  • Table 186. Canada Marijuana Sales, by Application Tons (2018-2023)
  • Table 187. Canada Marijuana Sales, by Grade Tons (2018-2023)
  • Table 188. Mexico Marijuana Sales, by Type Tons (2018-2023)
  • Table 189. Mexico Marijuana Sales, by Application Tons (2018-2023)
  • Table 190. Mexico Marijuana Sales, by Grade Tons (2018-2023)
  • Table 191. Marijuana: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Marijuana: by Type(USD Billion)
  • Table 202. Marijuana Recreational , by Region USD Billion (2025-2030)
  • Table 203. Marijuana Medical , by Region USD Billion (2025-2030)
  • Table 204. Marijuana: by Application(USD Billion)
  • Table 205. Marijuana Chronic Pain , by Region USD Billion (2025-2030)
  • Table 206. Marijuana Arthritis , by Region USD Billion (2025-2030)
  • Table 207. Marijuana Migraine , by Region USD Billion (2025-2030)
  • Table 208. Marijuana Cancer , by Region USD Billion (2025-2030)
  • Table 209. Marijuana Other , by Region USD Billion (2025-2030)
  • Table 210. Marijuana: by Grade(USD Billion)
  • Table 211. Marijuana Industrial Grade , by Region USD Billion (2025-2030)
  • Table 212. Marijuana Pharmaceutical Grade , by Region USD Billion (2025-2030)
  • Table 213. South America Marijuana, by Country USD Billion (2025-2030)
  • Table 214. South America Marijuana, by Type USD Billion (2025-2030)
  • Table 215. South America Marijuana, by Application USD Billion (2025-2030)
  • Table 216. South America Marijuana, by Grade USD Billion (2025-2030)
  • Table 217. Brazil Marijuana, by Type USD Billion (2025-2030)
  • Table 218. Brazil Marijuana, by Application USD Billion (2025-2030)
  • Table 219. Brazil Marijuana, by Grade USD Billion (2025-2030)
  • Table 220. Argentina Marijuana, by Type USD Billion (2025-2030)
  • Table 221. Argentina Marijuana, by Application USD Billion (2025-2030)
  • Table 222. Argentina Marijuana, by Grade USD Billion (2025-2030)
  • Table 223. Rest of South America Marijuana, by Type USD Billion (2025-2030)
  • Table 224. Rest of South America Marijuana, by Application USD Billion (2025-2030)
  • Table 225. Rest of South America Marijuana, by Grade USD Billion (2025-2030)
  • Table 226. Asia Pacific Marijuana, by Country USD Billion (2025-2030)
  • Table 227. Asia Pacific Marijuana, by Type USD Billion (2025-2030)
  • Table 228. Asia Pacific Marijuana, by Application USD Billion (2025-2030)
  • Table 229. Asia Pacific Marijuana, by Grade USD Billion (2025-2030)
  • Table 230. China Marijuana, by Type USD Billion (2025-2030)
  • Table 231. China Marijuana, by Application USD Billion (2025-2030)
  • Table 232. China Marijuana, by Grade USD Billion (2025-2030)
  • Table 233. Japan Marijuana, by Type USD Billion (2025-2030)
  • Table 234. Japan Marijuana, by Application USD Billion (2025-2030)
  • Table 235. Japan Marijuana, by Grade USD Billion (2025-2030)
  • Table 236. India Marijuana, by Type USD Billion (2025-2030)
  • Table 237. India Marijuana, by Application USD Billion (2025-2030)
  • Table 238. India Marijuana, by Grade USD Billion (2025-2030)
  • Table 239. South Korea Marijuana, by Type USD Billion (2025-2030)
  • Table 240. South Korea Marijuana, by Application USD Billion (2025-2030)
  • Table 241. South Korea Marijuana, by Grade USD Billion (2025-2030)
  • Table 242. Taiwan Marijuana, by Type USD Billion (2025-2030)
  • Table 243. Taiwan Marijuana, by Application USD Billion (2025-2030)
  • Table 244. Taiwan Marijuana, by Grade USD Billion (2025-2030)
  • Table 245. Australia Marijuana, by Type USD Billion (2025-2030)
  • Table 246. Australia Marijuana, by Application USD Billion (2025-2030)
  • Table 247. Australia Marijuana, by Grade USD Billion (2025-2030)
  • Table 248. Rest of Asia-Pacific Marijuana, by Type USD Billion (2025-2030)
  • Table 249. Rest of Asia-Pacific Marijuana, by Application USD Billion (2025-2030)
  • Table 250. Rest of Asia-Pacific Marijuana, by Grade USD Billion (2025-2030)
  • Table 251. Europe Marijuana, by Country USD Billion (2025-2030)
  • Table 252. Europe Marijuana, by Type USD Billion (2025-2030)
  • Table 253. Europe Marijuana, by Application USD Billion (2025-2030)
  • Table 254. Europe Marijuana, by Grade USD Billion (2025-2030)
  • Table 255. Germany Marijuana, by Type USD Billion (2025-2030)
  • Table 256. Germany Marijuana, by Application USD Billion (2025-2030)
  • Table 257. Germany Marijuana, by Grade USD Billion (2025-2030)
  • Table 258. France Marijuana, by Type USD Billion (2025-2030)
  • Table 259. France Marijuana, by Application USD Billion (2025-2030)
  • Table 260. France Marijuana, by Grade USD Billion (2025-2030)
  • Table 261. Italy Marijuana, by Type USD Billion (2025-2030)
  • Table 262. Italy Marijuana, by Application USD Billion (2025-2030)
  • Table 263. Italy Marijuana, by Grade USD Billion (2025-2030)
  • Table 264. United Kingdom Marijuana, by Type USD Billion (2025-2030)
  • Table 265. United Kingdom Marijuana, by Application USD Billion (2025-2030)
  • Table 266. United Kingdom Marijuana, by Grade USD Billion (2025-2030)
  • Table 267. Netherlands Marijuana, by Type USD Billion (2025-2030)
  • Table 268. Netherlands Marijuana, by Application USD Billion (2025-2030)
  • Table 269. Netherlands Marijuana, by Grade USD Billion (2025-2030)
  • Table 270. Rest of Europe Marijuana, by Type USD Billion (2025-2030)
  • Table 271. Rest of Europe Marijuana, by Application USD Billion (2025-2030)
  • Table 272. Rest of Europe Marijuana, by Grade USD Billion (2025-2030)
  • Table 273. MEA Marijuana, by Country USD Billion (2025-2030)
  • Table 274. MEA Marijuana, by Type USD Billion (2025-2030)
  • Table 275. MEA Marijuana, by Application USD Billion (2025-2030)
  • Table 276. MEA Marijuana, by Grade USD Billion (2025-2030)
  • Table 277. Middle East Marijuana, by Type USD Billion (2025-2030)
  • Table 278. Middle East Marijuana, by Application USD Billion (2025-2030)
  • Table 279. Middle East Marijuana, by Grade USD Billion (2025-2030)
  • Table 280. Africa Marijuana, by Type USD Billion (2025-2030)
  • Table 281. Africa Marijuana, by Application USD Billion (2025-2030)
  • Table 282. Africa Marijuana, by Grade USD Billion (2025-2030)
  • Table 283. North America Marijuana, by Country USD Billion (2025-2030)
  • Table 284. North America Marijuana, by Type USD Billion (2025-2030)
  • Table 285. North America Marijuana, by Application USD Billion (2025-2030)
  • Table 286. North America Marijuana, by Grade USD Billion (2025-2030)
  • Table 287. United States Marijuana, by Type USD Billion (2025-2030)
  • Table 288. United States Marijuana, by Application USD Billion (2025-2030)
  • Table 289. United States Marijuana, by Grade USD Billion (2025-2030)
  • Table 290. Canada Marijuana, by Type USD Billion (2025-2030)
  • Table 291. Canada Marijuana, by Application USD Billion (2025-2030)
  • Table 292. Canada Marijuana, by Grade USD Billion (2025-2030)
  • Table 293. Mexico Marijuana, by Type USD Billion (2025-2030)
  • Table 294. Mexico Marijuana, by Application USD Billion (2025-2030)
  • Table 295. Mexico Marijuana, by Grade USD Billion (2025-2030)
  • Table 296. Marijuana Sales: by Type(Tons)
  • Table 297. Marijuana Sales Recreational , by Region Tons (2025-2030)
  • Table 298. Marijuana Sales Medical , by Region Tons (2025-2030)
  • Table 299. Marijuana Sales: by Application(Tons)
  • Table 300. Marijuana Sales Chronic Pain , by Region Tons (2025-2030)
  • Table 301. Marijuana Sales Arthritis , by Region Tons (2025-2030)
  • Table 302. Marijuana Sales Migraine , by Region Tons (2025-2030)
  • Table 303. Marijuana Sales Cancer , by Region Tons (2025-2030)
  • Table 304. Marijuana Sales Other , by Region Tons (2025-2030)
  • Table 305. Marijuana Sales: by Grade(Tons)
  • Table 306. Marijuana Sales Industrial Grade , by Region Tons (2025-2030)
  • Table 307. Marijuana Sales Pharmaceutical Grade , by Region Tons (2025-2030)
  • Table 308. South America Marijuana Sales, by Country Tons (2025-2030)
  • Table 309. South America Marijuana Sales, by Type Tons (2025-2030)
  • Table 310. South America Marijuana Sales, by Application Tons (2025-2030)
  • Table 311. South America Marijuana Sales, by Grade Tons (2025-2030)
  • Table 312. Brazil Marijuana Sales, by Type Tons (2025-2030)
  • Table 313. Brazil Marijuana Sales, by Application Tons (2025-2030)
  • Table 314. Brazil Marijuana Sales, by Grade Tons (2025-2030)
  • Table 315. Argentina Marijuana Sales, by Type Tons (2025-2030)
  • Table 316. Argentina Marijuana Sales, by Application Tons (2025-2030)
  • Table 317. Argentina Marijuana Sales, by Grade Tons (2025-2030)
  • Table 318. Rest of South America Marijuana Sales, by Type Tons (2025-2030)
  • Table 319. Rest of South America Marijuana Sales, by Application Tons (2025-2030)
  • Table 320. Rest of South America Marijuana Sales, by Grade Tons (2025-2030)
  • Table 321. Asia Pacific Marijuana Sales, by Country Tons (2025-2030)
  • Table 322. Asia Pacific Marijuana Sales, by Type Tons (2025-2030)
  • Table 323. Asia Pacific Marijuana Sales, by Application Tons (2025-2030)
  • Table 324. Asia Pacific Marijuana Sales, by Grade Tons (2025-2030)
  • Table 325. China Marijuana Sales, by Type Tons (2025-2030)
  • Table 326. China Marijuana Sales, by Application Tons (2025-2030)
  • Table 327. China Marijuana Sales, by Grade Tons (2025-2030)
  • Table 328. Japan Marijuana Sales, by Type Tons (2025-2030)
  • Table 329. Japan Marijuana Sales, by Application Tons (2025-2030)
  • Table 330. Japan Marijuana Sales, by Grade Tons (2025-2030)
  • Table 331. India Marijuana Sales, by Type Tons (2025-2030)
  • Table 332. India Marijuana Sales, by Application Tons (2025-2030)
  • Table 333. India Marijuana Sales, by Grade Tons (2025-2030)
  • Table 334. South Korea Marijuana Sales, by Type Tons (2025-2030)
  • Table 335. South Korea Marijuana Sales, by Application Tons (2025-2030)
  • Table 336. South Korea Marijuana Sales, by Grade Tons (2025-2030)
  • Table 337. Taiwan Marijuana Sales, by Type Tons (2025-2030)
  • Table 338. Taiwan Marijuana Sales, by Application Tons (2025-2030)
  • Table 339. Taiwan Marijuana Sales, by Grade Tons (2025-2030)
  • Table 340. Australia Marijuana Sales, by Type Tons (2025-2030)
  • Table 341. Australia Marijuana Sales, by Application Tons (2025-2030)
  • Table 342. Australia Marijuana Sales, by Grade Tons (2025-2030)
  • Table 343. Rest of Asia-Pacific Marijuana Sales, by Type Tons (2025-2030)
  • Table 344. Rest of Asia-Pacific Marijuana Sales, by Application Tons (2025-2030)
  • Table 345. Rest of Asia-Pacific Marijuana Sales, by Grade Tons (2025-2030)
  • Table 346. Europe Marijuana Sales, by Country Tons (2025-2030)
  • Table 347. Europe Marijuana Sales, by Type Tons (2025-2030)
  • Table 348. Europe Marijuana Sales, by Application Tons (2025-2030)
  • Table 349. Europe Marijuana Sales, by Grade Tons (2025-2030)
  • Table 350. Germany Marijuana Sales, by Type Tons (2025-2030)
  • Table 351. Germany Marijuana Sales, by Application Tons (2025-2030)
  • Table 352. Germany Marijuana Sales, by Grade Tons (2025-2030)
  • Table 353. France Marijuana Sales, by Type Tons (2025-2030)
  • Table 354. France Marijuana Sales, by Application Tons (2025-2030)
  • Table 355. France Marijuana Sales, by Grade Tons (2025-2030)
  • Table 356. Italy Marijuana Sales, by Type Tons (2025-2030)
  • Table 357. Italy Marijuana Sales, by Application Tons (2025-2030)
  • Table 358. Italy Marijuana Sales, by Grade Tons (2025-2030)
  • Table 359. United Kingdom Marijuana Sales, by Type Tons (2025-2030)
  • Table 360. United Kingdom Marijuana Sales, by Application Tons (2025-2030)
  • Table 361. United Kingdom Marijuana Sales, by Grade Tons (2025-2030)
  • Table 362. Netherlands Marijuana Sales, by Type Tons (2025-2030)
  • Table 363. Netherlands Marijuana Sales, by Application Tons (2025-2030)
  • Table 364. Netherlands Marijuana Sales, by Grade Tons (2025-2030)
  • Table 365. Rest of Europe Marijuana Sales, by Type Tons (2025-2030)
  • Table 366. Rest of Europe Marijuana Sales, by Application Tons (2025-2030)
  • Table 367. Rest of Europe Marijuana Sales, by Grade Tons (2025-2030)
  • Table 368. MEA Marijuana Sales, by Country Tons (2025-2030)
  • Table 369. MEA Marijuana Sales, by Type Tons (2025-2030)
  • Table 370. MEA Marijuana Sales, by Application Tons (2025-2030)
  • Table 371. MEA Marijuana Sales, by Grade Tons (2025-2030)
  • Table 372. Middle East Marijuana Sales, by Type Tons (2025-2030)
  • Table 373. Middle East Marijuana Sales, by Application Tons (2025-2030)
  • Table 374. Middle East Marijuana Sales, by Grade Tons (2025-2030)
  • Table 375. Africa Marijuana Sales, by Type Tons (2025-2030)
  • Table 376. Africa Marijuana Sales, by Application Tons (2025-2030)
  • Table 377. Africa Marijuana Sales, by Grade Tons (2025-2030)
  • Table 378. North America Marijuana Sales, by Country Tons (2025-2030)
  • Table 379. North America Marijuana Sales, by Type Tons (2025-2030)
  • Table 380. North America Marijuana Sales, by Application Tons (2025-2030)
  • Table 381. North America Marijuana Sales, by Grade Tons (2025-2030)
  • Table 382. United States Marijuana Sales, by Type Tons (2025-2030)
  • Table 383. United States Marijuana Sales, by Application Tons (2025-2030)
  • Table 384. United States Marijuana Sales, by Grade Tons (2025-2030)
  • Table 385. Canada Marijuana Sales, by Type Tons (2025-2030)
  • Table 386. Canada Marijuana Sales, by Application Tons (2025-2030)
  • Table 387. Canada Marijuana Sales, by Grade Tons (2025-2030)
  • Table 388. Mexico Marijuana Sales, by Type Tons (2025-2030)
  • Table 389. Mexico Marijuana Sales, by Application Tons (2025-2030)
  • Table 390. Mexico Marijuana Sales, by Grade Tons (2025-2030)
  • Table 391. Marijuana: by Type(USD/Units)
  • Table 392. Research Programs/Design for This Report
  • Table 393. Key Data Information from Secondary Sources
  • Table 394. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Marijuana: by Type USD Billion (2018-2023)
  • Figure 5. Global Marijuana: by Application USD Billion (2018-2023)
  • Figure 6. Global Marijuana: by Grade USD Billion (2018-2023)
  • Figure 7. South America Marijuana Share (%), by Country
  • Figure 8. Asia Pacific Marijuana Share (%), by Country
  • Figure 9. Europe Marijuana Share (%), by Country
  • Figure 10. MEA Marijuana Share (%), by Country
  • Figure 11. North America Marijuana Share (%), by Country
  • Figure 12. Global Marijuana: by Type Tons (2018-2023)
  • Figure 13. Global Marijuana: by Application Tons (2018-2023)
  • Figure 14. Global Marijuana: by Grade Tons (2018-2023)
  • Figure 15. South America Marijuana Share (%), by Country
  • Figure 16. Asia Pacific Marijuana Share (%), by Country
  • Figure 17. Europe Marijuana Share (%), by Country
  • Figure 18. MEA Marijuana Share (%), by Country
  • Figure 19. North America Marijuana Share (%), by Country
  • Figure 20. Global Marijuana: by Type USD/Units (2018-2023)
  • Figure 21. Global Marijuana share by Players 2023 (%)
  • Figure 22. Global Marijuana share by Players (Top 3) 2023(%)
  • Figure 23. Global Marijuana share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Cara Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cara Therapeutics (United States) Revenue: by Geography 2023
  • Figure 27. Cannabis Sativa (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cannabis Sativa (United States) Revenue: by Geography 2023
  • Figure 29. CannaGrow Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 30. CannaGrow Holdings (United States) Revenue: by Geography 2023
  • Figure 31. United Cannabis (United States) Revenue, Net Income and Gross profit
  • Figure 32. United Cannabis (United States) Revenue: by Geography 2023
  • Figure 33. Growblox Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 34. Growblox Sciences (United States) Revenue: by Geography 2023
  • Figure 35. GreenGro Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 36. GreenGro Technologies (United States) Revenue: by Geography 2023
  • Figure 37. GW Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. GW Pharmaceuticals (United Kingdom) Revenue: by Geography 2023
  • Figure 39. Lexaria Corp (Canada) Revenue, Net Income and Gross profit
  • Figure 40. Lexaria Corp (Canada) Revenue: by Geography 2023
  • Figure 41. MMJ America (United States) Revenue, Net Income and Gross profit
  • Figure 42. MMJ America (United States) Revenue: by Geography 2023
  • Figure 43. Global Marijuana: by Type USD Billion (2025-2030)
  • Figure 44. Global Marijuana: by Application USD Billion (2025-2030)
  • Figure 45. Global Marijuana: by Grade USD Billion (2025-2030)
  • Figure 46. South America Marijuana Share (%), by Country
  • Figure 47. Asia Pacific Marijuana Share (%), by Country
  • Figure 48. Europe Marijuana Share (%), by Country
  • Figure 49. MEA Marijuana Share (%), by Country
  • Figure 50. North America Marijuana Share (%), by Country
  • Figure 51. Global Marijuana: by Type Tons (2025-2030)
  • Figure 52. Global Marijuana: by Application Tons (2025-2030)
  • Figure 53. Global Marijuana: by Grade Tons (2025-2030)
  • Figure 54. South America Marijuana Share (%), by Country
  • Figure 55. Asia Pacific Marijuana Share (%), by Country
  • Figure 56. Europe Marijuana Share (%), by Country
  • Figure 57. MEA Marijuana Share (%), by Country
  • Figure 58. North America Marijuana Share (%), by Country
  • Figure 59. Global Marijuana: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Cara Therapeutics (United States)
  • Cannabis Sativa (United States)
  • CannaGrow Holdings (United States)
  • United Cannabis (United States)
  • Growblox Sciences (United States)
  • GreenGro Technologies (United States)
  • GW Pharmaceuticals (United Kingdom)
  • Lexaria Corp (Canada)
  • MMJ America (United States)
Additional players considered in the study are as follows:
Canopy Growth (Canada) , Aphria (Canada) , Aurora Cannabis Inc.(Canada) , mCig Inc. (United States) , Medicine Man (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 241 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Marijuana Market review Quantitative research analysis
Global Marijuana Market review Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Cara Therapeutics (United States), Cannabis Sativa (United States), CannaGrow Holdings (United States), United Cannabis (United States), Growblox Sciences (United States), GreenGro Technologies (United States), GW Pharmaceuticals (United Kingdom), Lexaria Corp (Canada) and MMJ America (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Emergence of luxury cannabis products " is seen as one of major influencing trends for Marijuana Market during projected period 2023-2030.
The Marijuana market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Marijuana Market review Report?

Have a Query? Click Here

Other Related Reports

Gorse Comprehensive Study by Industry Vertical (Food and Beverages Industry, Pharmaceutical Industry, Retail), Distribution Channel (Direct Sales, Indirect Sales (Specialty Store, E-Retailers, Modern...
$ 3450
Birch Wood Comprehensive Study by Type (Log, Board, Others), Application (Flooring, Furniture, Musical Instrument, Skateboards, Others), Category (Baltic Birch, Yellow Birch, Sweet Birch, Downy Birch...
$ 3800
Slingshot Comprehensive Study by Type (Traditional, Modern), Application (Hunting, Sports, Military Use, Others), Sales Channel (Online, Offline) Players and Region - Global Market Outlook to 2027
$ 3500
Natural Dyes Comprehensive Study by Type (Animal-Based, Mineral-Based, Plant-Based), End Users (Food & Beverage, Textile & Leather, Pharmaceutical, Cosmetics, Others) Players and Region - Global Mark...
$ 3500
Carnauba Wax Comprehensive Study by Application (Coatings, Automotive, Polishes, Industrial applications), End users (Food and beverage, Pharmaceuticals, Cosmetics, Automotive, Others), Form (Powder,...
$ 3350
Solid Hardwood Flooring Comprehensive Study by Type (Alder Solid Hardwood Flooring, Balsa Solid Hardwood Flooring, Beech Solid Hardwood Flooring, Hickory Solid Hardwood Flooring, Mahogany Solid Hardw...
$ 3750